- USPLabs agrees to recall and destroy dietary supplement following FDA actions
- Obesity drug beloranib shows promise in Prader-Willi population in Phase 2 trials
- Reports: Bill to extend federal regulations for compounding pharmacies expected to pass House, Senate
- Study: 2,000 IUs of vitamin E daily effective in slowing functional decline in AD patients
- Ensuring access to chronic pain medications
SILVER SPRING, Md. — The Food and Drug Administration on Tuesday advised consumers not to purchase or use “MAXILOSS Weight Advanced” — a product promoted and sold for weight loss on various web sites, including DreamLifeWeightLoss.com, and in some retail stores.
FDA laboratory analysis confirmed that “MAXILOSS Weight Advanced” contains sibutramine, a controlled substance that was removed from the market in October 2010 for safety reasons. The product poses a threat to consumers because sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias or stroke. This product may also interact in life-threatening ways with other medications a consumer may be taking.
Consumers should stop using this product immediately and throw it away. Consumers who have experienced any negative side effects should consult a healthcare professional as soon as possible.
This notification is to inform the public of a growing trend of dietary supplements or conventional foods with hidden drugs and chemicals, the FDA noted. These products are typically promoted for sexual enhancement, weight loss and body-building and are often represented as being “all natural.”